Evidence map›Paper›PMID 39960954›Full record

ReviewMedicine2025

Case report and literature review: Misdiagnoses of contrast encephalopathy as stroke.

Xiangjia Qi, Liqian Gao, Lifeng Qi

Abstract readCase ReportsReview
In one paragraph

Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiangjia QiDepartment of Neurology, Liaocheng People's Hospital, Liaocheng, China.
Liqian Gao

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleContrast-induced encephalopathy (CIE) is a rare complication following carotid artery stenting, often mimicking stroke symptoms such as focal neurological deficits. Its transient nature and reversibility necessitate differentiation from critical complications like cerebral hemorrhage or infarction, as management strategies differ substantially. This case underscores the diagnostic challenges and clinical implications of CIE in endovascular procedures. PATIENT CONCERNS: A 65-year-old woman with a history of cerebral infarction and prior carotid artery stenting presented with persistent numbness in her extremities for over 1 month. Post-carotid artery stenting, she developed acute slurred speech and right-sided limb weakness within 1 hour, raising concerns for stroke or procedural complications. DIAGNOSES: Emergency cranial computed tomography revealed left cerebral hemisphere swelling and linear hyperdensities, while magnetic resonance imaging demonstrated punctate diffusion-weighted imaging hyperintensities in the left parietal lobe. Temporal correlation of symptoms with iodixanol contrast administration (150 mL) supported a diagnosis of CIE, excluding acute infarction or hemorrhage.

interventionsImmediate management included antiplatelet therapy (tirofiban), thrombolysis (urokinase), corticosteroids (methylprednisolone), and antiedema agents (mannitol and albumin). Supportive care emphasized hydration and neurological monitoring. OUTCOMES: The patient exhibited progressive improvement, with complete resolution of speech and motor deficits by postoperative day 3. Neuroimaging abnormalities regressed, aligning with the transient nature of CIE. LESSONS: This case highlights the critical role of prompt neuroimaging to exclude life-threatening differentials and confirms CIE's reversibility with supportive care. Risk factors such as contrast volume and cerebral circulation dynamics warrant attention. Clinicians should exercise caution in readministering iodinated contrast to patients with prior CIE episodes.

Indexed as

Brain DiseasesContrast MediaDiagnostic ErrorsStrokeAgedDiagnosis, DifferentialFemaleHumansStentsTomography, X-Ray ComputedTriiodobenzoic AcidsContrast MediaiodixanolTriiodobenzoic Acids

Identifiers

PMID39960954
PMCPMC11835061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.